U.S. compounding pharmacy-related outbreaks, 2001–2013: public health and patient safety lessons learned.
Shehab N, Brown MN, Kallen AJ, Perz JF. J Patient Saf. 2015 May 21; [Epub ahead of print].
Pharmacy-compounded sterile preparations have been linked to infection outbreaks in recent years. This review analyzes the evidence to determine the incidence of this trend, identify contributing factors, and explore strategies to reduce its impact on public health and patient safety.
Health care–associated invasive MRSA infections, 2005–2008.
Kallen AJ, Mu Y, Bulens S, et al; Active Bacterial Core surveillance (ABCs) MRSA Investigators of the Emerging Infections Program. JAMA. 2010;304:641-648.
National Healthcare Safety Network.
Centers for Disease Control and Prevention.
Influence of state laws mandating reporting of healthcare-associated infections: the case of central line–associated bloodstream infections.
Pakyz AL, Edmond MB. Infect Control Hosp Epidemiol. 2013;34:780-784.
MULTI-USE WEBSITEView all related resources...
Healthcare–Associated Infections (HAI).
Atlanta, GA: Centers for Disease Control and Prevention.